Table 3.
Association of Stasys assays and patients receiving transfusions
| Transfusions at 0–6 hours | Transfusions at 0–24 hours | |||||||
| Any products (n=32; 30%) |
pRBCs (n=31; 29%) |
FFP (n=27; 25%) |
PLT (n=14; 11%) |
Any products (n=34; 31%) |
pRBCs (n=33; 30%) |
FFP (n=29; 27%) |
PLT (n=17; 14%) |
|
| Platelet contractile force | ||||||||
| Cumulative | 25 593 (0.04*) |
25 193 (0.04*) |
25 832 (0.12) |
24 815 (0.18) |
29 570 (0.02*) |
33 308 (0.03*) |
33 301 (0.09) |
33 569 (0.37) |
| Maximum | 203.27 (0.04*) |
206.40 (0.06) |
200.13 (0.06) |
174.32 (0.03*) |
207.26 (0.02*) |
208.11 (0.03*) |
205.88 (0.03*) |
198.50 (0.09) |
| Clot area | ||||||||
| Cumulative | 55.40 (0.99) |
52.52 (0.95) |
49.74 (0.51) |
49.40 (0.99) |
56.42 (0.57) |
51.59 (0.54) |
49.74 (0.22) |
49.46 (0.71) |
| Maximum | 0.26 (0.72) |
0.26 (0.83) |
0.24 (0.69) |
0.23 (0.89) |
0.26 (0.80) |
0.26 (0.92) |
0.26 (0.62) |
0.22 (0.81) |
Data presented as median and p values for comparison of transfused versus non-transfused patients, using Kruskal-Wallis test listed above. Portion of cohort receiving transfusion reported as absolute value and percentage.
*Indicates statistically significant findings of p≤0.05.
FFP, fresh frozen plasma; PLT, platelets; pRBCs, packed red blood cells.